Related Experiment Videos
Positron emission tomography in primary brain tumours using cobalt-55
H M Jansen1, R A Dierckx, J M Hew
1Department of Neurology, Groningen University Hospital, The Netherlands.
Nuclear Medicine Communications
|August 1, 1997
Summary
Cobalt-55 (55Co) positron emission tomography (PET) visualizes decaying brain tumor tissue by tracking calcium influx. This novel nuclear neurology technique shows promise for detailed tumor assessment.
Area of Science:
- Nuclear Medicine
- Oncology
- Radiochemistry
Background:
- Primary brain tumors are typically evaluated using computed tomography (CT), magnetic resonance imaging (MRI), and sometimes positron emission tomography (PET).
- Calcium influx is critical for cell death and leukocyte activation, suggesting its potential as a tracer for visualizing tumor decay.
Observation:
- Cobalt-55 (55Co) was used as a calcium tracer in three patients with primary malignant brain tumors.
- Co-PET imaging was performed alongside CT and MRI after intravenous administration of 55Co.
- Histopathological diagnosis was confirmed via biopsy or resection.
Findings:
- Co-PET successfully visualized all brain tumors, showing good agreement with CT and MRI.
- 55Co-PET provided enhanced detail on the necrotic core and perinecrotic rim of decaying tumor tissue.
- 55Co demonstrated uptake in decaying tissue, independent of blood-brain barrier integrity, with uptake indices ranging from 2.6 to 5.3.
Implications:
- Cobalt-55 (55Co) positron emission tomography (PET) offers a novel functional imaging technique for nuclear neurology.
- This method can provide additional details on tumor necrosis and cellular decay not fully captured by conventional imaging.
- The applicability of 55Co to both PET and single photon emission tomography (SPET) warrants further investigation into its uptake mechanisms and functional significance.